Trials / Withdrawn
WithdrawnNCT04537975
C2Rx Hemofiltration Treatment in Severe or Critically Ill Adults With COVID-19
A Randomized Clinical Trial of CLR2.0 Hemofiltration Treatment (C2Rx) in Severe or Critically Ill Adults With COVID-19 Infection
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- SeaStar Medical · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The clinical trial will evaluate the short term and extended impact on on respiration, pulmonary function and cardiovascular function in C2Rx treatment verse Standard of Care (SOC) in critically ill adults with COVID-19 infections .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | C2Rx | Hemofiltration |
| OTHER | Standard of Care (SOC) | Standard of care that excludes any protocol restrictions. |
Timeline
- Start date
- 2020-09-15
- Primary completion
- 2020-11-15
- Completion
- 2021-01-15
- First posted
- 2020-09-03
- Last updated
- 2020-12-14
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04537975. Inclusion in this directory is not an endorsement.